GlassScriptPhysician profile
Kevin P Cope
NPI 1861498248
$835.72
in general payments reported to CMS, 2019-2025
21 companies · $62.47 in 2025
The $62.47 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $578 · 2022: $21.00 · 2023: $45.51 · 2024: $129 · 2025: $62.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $236.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braeburn INC. | $154.89 | 2023-2025 | Brixadi |
| Novo Nordisk INC | $116.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.65 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $60.35 | 2019 | |
| Abbvie INC. | $59.62 | 2024-2025 | |
| Indivior INC. | $57.78 | 2019-2024 | Sublocade |
| Sanofi-Aventis U.S. LLC | $30.97 | 2019 | |
| Pfizer INC. | $29.95 | 2019 | |
| Merck Sharp & Dohme LLC | $26.69 | 2019 | |
| Radius Health, INC. | $23.32 | 2019 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Neurocrine Biosciences, INC. | $17.54 | 2019 | |
| Orexo US, INC. | $16.86 | 2019 | |
| Amarin Pharma, INC. | $15.94 | 2019 | |
| Seqirus USA INC | $15.45 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $14.96 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $13.97 | 2019 | |
| Bausch Health US, LLC | $13.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.41 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.